Avastin not ban in Singapore, HSA still reviewing FDA report

TopNews United States, 18 Dec 2010On Thursday, the US Food and Drug Administration (FDA) declared that Avastin is not suggested for breast cancer treatment as it has not been found effective in reducing the impact of the disease and also inflicts side-effects as per recent studies on it. But still the drug is being allowed to market in Singapore as review on it is under process. Full story